Results 201 to 210 of about 44,369 (290)

Flecainide in Structural Heart Disease: Reconsidering Its Role in Contemporary Arrhythmia Management. [PDF]

Life (Basel)
Karakasis P, Grigoriou K, Theofilis P, Iliakis P, Vlachakis PK, Ktenopoulos N, Apostolos A, Patoulias D, Antoniadis AP, Fragakis N.   +9 more
europepmc   +1 more source

Association Between Left Ventricular Diastolic Dysfunction and Subsequent Detection of Sick Sinus Syndrome and Atrial Fibrillation in Patients With Unexplained Syncope

Journal of Arrhythmia, Volume 42, Issue 3, June 2026.
Among patients with recurrent unexplained syncope and no prior AF, LV diastolic dysfunction quantified by the HFA‐PEFF score predicts sick sinus syndrome and atrial fibrillation. ABSTRACT Background Atrial fibrillation (AF) and sick sinus syndrome (SSS) frequently coexist and may share common atrial structural and electrophysiological remodeling ...
Hironobu Sumiyoshi, Hidemori Hayashi, Akira Nakashima, Toshikazu Kono, Maki Ono, Akira Mizukami, Tohru Minamino   +6 more
wiley   +1 more source

Potential Antiarrhythmic Mechanisms of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs). [PDF]

Drug Des Devel Ther
Li J, Fu K, Zhao J, Zou Y, Li L, Huang Q, Long L, Ou X, Lei M, Zhang C, Tan X, Chen T.   +11 more
europepmc   +1 more source

Efficacy of omega‐3 fatty acids as a functional food: a multifaceted approach to health reinforcement

Journal of the Science of Food and Agriculture, Volume 106, Issue 8, Page 4521-4549, June 2026.
Abstract Omega‐3 fatty acids (omega‐3s) are polyunsaturated fatty acids linked with numerous health benefits. Omega‐3s exhibit multifaceted activities through various mechanisms. Eicosapentaenoic acid (EPA) alleviates oxidative stress by lowering reactive oxygen species and improving oxidative stress in brain tissues and acts against neurodegenerative ...
Md Faruque Ahmad, Abdulrahman A Alsayegh, Anjum Khanam, Awais Ahmed, António Raposo, Farkad Bantun, Md Zeyaullah, Ahmad O Babalghith, Abdullah F Aldairi, Boshra Mozaffar, Mohammed F Bajahzer, Mohamed H Abdelrahman, Mohammad Intakhab Alam   +12 more
wiley   +1 more source

Propafenone Toxicity Presenting With Wide QRS and Transient Ventricular Dyskinesia. [PDF]

JACC Case Rep
Araújo de Lucena L, da Costa Fernandes Mesquita F, Rigon Madeira M, Saraiva da Silva Maia FG.   +3 more
europepmc   +1 more source

Trends in Atrial Fibrillation‐Related Mortality Among Adults With Obesity in the United States From 1999 to 2024

Obesity Science &Practice, Volume 12, Issue 3, June 2026.
ABSTRACT Background Atrial fibrillation (AF) is a prevalent cardiac arrhythmia associated with increased mortality, particularly among individuals with obesity. This study examined trends in AF‐related mortality in adults with obesity in the United States from 1999 to 2024.
Aymen Ahmed, Ruqiat Masooma Batool, Saad Ahmed Waqas, Hasan Fareed Siddiqui, Muhammad Sameer Arshad, Neha Saleem Paryani, Izza Shahid, Hasibullah Aminpoor, Ali Mithani, Muhammad Talha Ayub   +9 more
wiley   +1 more source

Benzofuran‐Based Uricosuric Agents: History, Roles, and Challenges

ChemistrySelect, Volume 11, Issue 24, 25 June 2026.
Benzofuran‐based uricosuric agents represent a privileged medicinal chemistry scaffold for gout therapy. Structural optimization of benzbromarone‐related derivatives has improved hURAT1 inhibitory potency, metabolic stability, and urate‐lowering efficacy, while reducing hepatotoxic liability.
Raed M. Al‐Zoubi, Basma Hanbali, Mai Elaarag, Zainab Fares, Enas A. Al‐Hurani, Sally R. Al‐Zoubi, Mohanad Shkoor, Abdelali Agouni   +7 more
wiley   +1 more source

Dual HeartMate 3 in total artificial heart configuration for incessant ventricular fibrillation: a case report. [PDF]

Eur Heart J Case Rep
Fu HY, Then WZ, Tsao CI, Chen YS.
europepmc   +1 more source

Effects of Nacubactam and Its Metabolites on QTc Interval: A Pooled Analysis of Two Randomized Phase 1 Studies

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Nacubactam is a β‐lactamase inhibitor. Early‐phase studies with 1000/2000/4000/8000 mg nacubactam monotherapy were not powered to assess proarrhythmic risk. Therefore, this analysis pooled electrocardiogram data from two placebo‐controlled studies to quantify potential effects of nacubactam on cardiac repolarization.
Jun Morita, Sue McKendrick, Yuji Kumagai
wiley   +1 more source

Correction to: Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. [PDF]

Europace
europepmc   +1 more source